Jose Luis
Alonso Romero
Asociado Ciencias de la Salud
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Virgen del Rocío (3)
2024
2022
2021
-
Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial
European Journal of Cancer, Vol. 148, pp. 382-394